Loading...
PhD Simona Borštnar

PhD Simona Borštnar
no.: 16303 source: ARIS

researcher – active in research organisation
Phone number (01) 587 92 84
E-mail sborstnarat signonko-i.si
Foreign language skills
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
Keywords
breast neoplasms, urokinase, plasminogen activator inhibitor 1, plasminogen activator inhibitor 2, prognosis
Points
255.01
A''
31.49
A'
90.82
A1/2
105.08
CI10
1,776
CImax
1,012
h10
12
A1
0.83
A3
4.18
Data for the last 5 years (citations for the last 10 years) on April 17, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 60  1,873  1,842  30.7 
Scopus 45  2,371  2,339  51.98 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
    Medicine  SI University of Ljubljana, Faculty of Medicine 1993 
Master's degree  M. Sc.   Oncology  SI University of Ljubljana, Faculty of Medicine 1998 
Doctor's degree    Medical sciences  SI University of Ljubljana, Faculty of Medicine 2003 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position ecris.org.employ_rolegroup Title
Full time employment (100%, RD:20%)  Institute of Oncology Ljubljana  Department of research  12/1/1995  Resident of internal medicine  Researcher   
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J3-3062  Autologous immunohybridomas and advanced treatment of stage II and III triple-negative breast cancer   2021 - 2024  PhD Matjaž Jeras  2,520 
2. V3-1906  Pilot study on individualized integrated rehabilitation of breast cancer patients 2019-2022   2019 - 2023  PhD Nikola Bešić  3,904 
3. V3-1048  Izdelava strokovnih podlag za zbiranje in spremljanje izbranih kazalnikov učinkovitosti Državnega programa obvladovanja raka (Slovene)   2010 - 2012  PhD Maja Primic-Žakelj  5,276 
4. J3-0124  The role of recombinant human erythropoietin on gene expression and signal transduction in breast cancer   2008 - 2011  PhD Nataša Debeljak  3,805 
5. L3-6059  Prospektivna randomizirana klinična raziskava faze ll: 5-FU/LV in Irinotekan v primerjavi s kombinacijo Kapecitabin in Irinotekan v prvem zdravljenju metastatske bolezni pri bolnikih s karcinomom debelega črevesa in danke (Slovene)   2004 - 2007  PhD Janja Ocvirk  1,839 
6. J3-4291  Napovedni pomen proteinov uPA sistema za odgovor na sistemsko zdravljenje in za lokalno ponovitev bolezni pri bolnicah z rakom dojk (Slovene)   2002 - 2005  PhD Tanja Čufer  4,470 
7. J3-2165  Napovedni pomen proteinov uPA sistema in katepsinov za prezivetje in odgovor na sistemsko zdravljenje bolnic z rakom dojk (Slovene)   2002  PhD Tanja Čufer  4,534 
8. L3-1192  PovejMi: telemedicinska pomoč bolnicam z rakom dojke (Slovene)   1999 - 2001  PhD Ankica Babič  3,775 
9. J3-0123  Protitelesa proti proteinu p53 in p53 v serumu bolnikov z malignimi tumorji (Slovene)   1998 - 2001  PhD Zvonimir Rudolf  3,627 
ARIS research and infrastructure programmes Legend
source: ARIS
Views history
Favourite